The Genentech Medical Affairs team is trying to recruit PPMS patients and their support partners for an advisory board this fall (2016)

August 22, 2016 /
For the Benefit of the Patient


                                                                  

  


Click here to receive MS news via e-mail



AD (advisory) BOARD RECRUITMENT INFO

A pharmaceutical/biotech company is in the process of developing
a new potential multiple sclerosis (MS) therapy and will be hosting a small
Patient/Care-partner Advisory Board meeting on Thursday, November 3, 2016 in
Chicago, IL.

At this one-day meeting, people with a diagnosis of primary
progressive multiple sclerosis (PPMS) and their Support partners will be
invited to share their experiences and challenges living with PPMS. This advice
will inform the pharmaceutical/biotech company’s work in providing information
about the product and appropriately engaging with the MS community.

The pharmaceutical/biotech company will reimburse the travel
expenses of invited participants, and provide an honorarium as thanks for their
time and participation. 

Participants must:
  • be between the ages of 18 and 55
  • have a diagnosis (made by a physician)
    of PPMS for 3 to 10 years
  • not currently be participating in an MS
    drug clinical trial
  • be interested in participating, with or
    without a care-partner; and
  • be willing and able to travel to
    Chicago, IL, for a one-day meeting on Thursday, November 3rd.  The
    meeting will be held at a hotel near the Chicago O’Hare International
    Airport.
     
If you are interested in attending, please contact Sam Wunderle
at Stem Scientific by email or phone.
201-271-6160

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews

Stay informed with MS news and information - Sign-up here

For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT


Share:

Categories

Latest Blog Posts